Solid tumor growth depends on an intricate equilibrium of malignant cell states
Stefan Torborg(Memorial Sloan Kettering Cancer Center), Tuomas Tammela(Memorial Sloan Kettering Cancer Center), Andre Levchenko(Yale University), Lukas E. Dow(Cornell University), Katherine Wu(New York University), Anupriya Singhal(Memorial Sloan Kettering Cancer Center), Olivera Grbovic-Huezo(Memorial Sloan Kettering Cancer Center), Francisco J. Sánchez‐Rivera(Howard Hughes Medical Institute), Kenneth L. Pitter(Memorial Sloan Kettering Cancer Center), Caj Haglund(University of Helsinki), Yu-Jui Ho(Memorial Sloan Kettering Cancer Center), Michael J. Mitchell(California Institute for Regenerative Medicine), Matilda Holm(University of Helsinki), Scott W. Lowe(Memorial Sloan Kettering Cancer Center), Xuexiang Han(Center for Excellence in Molecular Cell Science)
Cited by 3
Related Papers
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
|Nature|2017|1.2k
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
|Clinical Chemistry|2008|1.1k
Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity
|Genes & Development|2011|990